We report a median age of 50 years; 68.8% of tumours being hormone receptor-positive and 86% LN positive, as compared to a median age of 49–50 years, hormone receptor-positive 48–62% and LN positive 70–76% in pivotal studies [2–6]. Here, NR4A1 is linked to neoplasm.